Navigation Links
Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
Date:8/3/2009

inum, represents a important improvement in the design and tolerability of platinum chemotherapies.

Later this month, an Access management and clinical development team is meeting with Access' partner, Aosaikang Medicinal Group (ASK) and several key oncology opinion leaders to finalize plans for ProLindac development in China. In addition, Access is meeting with its Korean partner, JCOM of Seoul, South Korea to finalize development plans in that territory. Access believes that three ProLindac combination trials will start shortly upon regulatory approvals of protocols in both China and Korea. Further, Access has reported receipt of additional milestone payments from its Far East partners in the ordinary course under their collaborative agreements.

"Our Chinese partner, ASK, has made great progress on manufacturing scale-up of ProLindac and advancing the Regulatory process with the SFDA. We are excited about finalizing protocols with ASK and the leading oncologists in China, and look forward to their continued progress," stated Jeffrey B. Davis, Access' President and CEO. "Additionally, we are meeting this month with JCOM and key opinion leaders in Korea, and hope to get the combination trials started in Korea as soon as reasonably possible."

Access intends to design all clinical studies of ProLindac in accordance with FDA standards and intends to use the clinical data from all three planned clinical trials in the Far East to further development in North America and Europe. Access has the right to all clinical data generated in the Far East under the agreements entered into with their Far East partners, and as previously announced, believes that these trials run by its ProLindac partners will save Access between $20 and $30 million in clinical development expenses.

Access is currently in discussion with potential partners for
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
2. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
3. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
4. Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
5. First U.S. Patients Enrolled in the REALISM Continued Access Study
6. Access Pharmaceuticals Presents new Combination Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
7. Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries
8. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
9. Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures
10. St. Jude Study Gives New Insights Into How Cells Accessorize Their Proteins
11. McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015  DICOM Grid,  the #1 ... it was recognized as a semifinalist for a ... The awards are sponsored by Auntminnie.com, a ... in the medical imaging industry.  Since 1999, the ... to acknowledge the contributions of their peers. Nominations ...
(Date:8/31/2015)... JERUSALEM, Israel, Aug. 31, 2015  Chiasma, Inc. ... company developing octreotide capsules for the orphan condition ... quarter ended June 30, 2015 and provided a ... have been a transformative time for Chiasma, as ... recently announced that our first New Drug Application ...
(Date:8/31/2015)... Thousands of people will peacefully demonstrate their ... addiction epidemic at dozens of rallies across the country ... the United States has experienced skyrocketing ... and heroin, yet the President has never once spoken ... letter to President Obama , rally organizers compared his ...
Breaking Medicine Technology:DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 3Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 4Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 5Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 6Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 7Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 8Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 9Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2
(Date:8/31/2015)... ... 01, 2015 , ... The PT Outcomes Registry is an organized system for ... patients. The Registry is being developed by the American Physical Therapy Association (APTA). , ... be selected to contribute FOTO Outcomes measures as one of the primary global outcomes ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... in giving potential patients the resources they need to have a successful cosmetic ... board certified plastic surgeons; Cosmetic Town Journal is always ready to help. , ...
(Date:8/31/2015)... ... August 31, 2015 , ... When it comes to undergoing a hair transplant, most patients ... head. Adding more volume to the hair on top of the scalp, as well ... a good amount of donor hair on other areas of their head. , What about ...
(Date:8/31/2015)... ... , ... The Lisle family law firm of Momkus McCluskey, LLC ... peers to earn a “Leading Lawyers” distinction. , The “Leading Lawyers” ... Illinois. The nomination process is based on statewide peer survey nominations and the approval ...
(Date:8/31/2015)... ... 31, 2015 , ... CareSource, a nonprofit Ohio-based health plan, ... capacity, Michael will provide strategic leadership for CareSource’s marketing, branding, corporate communications and ... have contributed to the company’s rapid growth. As the CareSource business model expands ...
Breaking Medicine News(10 mins):Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2Health News:Body Hair Transplants to Help Achieve a Full Head of Hair 2Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:CareSource Names Vice President, Marketing and Corporate Communications 2
... Insurance recipients; time-intensive process of receiving benefits can include 60 to ... ... Belleville, Ill. (Vocus) June 25, 2008 -- The number of people ... to grow in 2007. This means more people are asking questions ...
... percent of patients admitted to the hospital have alcohol/drug ... risen sharply in recent years, according to a study ... Substance Abuse Treatment (JSAT). , "Our results ... ADAA and the striking financial costs placed on the ...
... but safety an issue in poorer areas, analysis finds ... million major surgeries are performed worldwide each year, and ... in low-income countries, U.S. researchers report. , Dr. Thomas ... his colleagues defined major surgeries as any incision, excision, ...
... Fla., June 25 Pharmavite, a ... chosen the on-line consumer-centric,program, LearnSomethingAbout(TM), as ... created the engaging, consumer-oriented multimedia,program that ... national retailers., "LearnSomething shares similar ...
... CYNO ), a leading developer and manufacturer of a ... opening of its,second sales office in the People,s Republic ... the office will be headed by Aileen Ren, vice,general ... company,s,wholly owned subsidiary. Cynosure also has a sales office ...
... June 25 LCA-Vision Inc. (Nasdaq:,LCAV), a ... under the,LasikPlus(R) brand, is providing an update ... market conditions for the company,s services., ... and discretionary spending, leading to continued softness ...
Cached Medicine News:Health News:SSDI Recipients Ask: When Do I Get My Benefits? 2Health News:SSDI Recipients Ask: When Do I Get My Benefits? 3Health News:Study shows high rates, rising costs of alcohol/drug disorders in hospitalized patients 2Health News:Worldwide Surgery Rates Tied to Economic Status 2Health News:Pharmavite Partners With LearnSomething, Inc. on Consumer Education Program, LearnSomethingAbout(TM) 2Health News:Cynosure Expands Presence in China with the Opening of Sales Office in Beijing 2Health News:LCA-Vision Provides Business Update and Market Review 2Health News:LCA-Vision Provides Business Update and Market Review 3Health News:LCA-Vision Provides Business Update and Market Review 4
This is an Immunological assay intended for the quantitative in vitro determination of haemoglobin A1c (HbA1c) in whole blood....
For the quantitative in vitro determination of Potassium in serum or plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
For the quantitative in vitro determination of Valproic Acid in human serum...
Medicine Products: